Skip to Main Content

Advertisement

Skip Nav Destination

Abstract 3014: Pharmacokinetics of the CDC7 inhibitor LY3143921 hydrate, a CRUK first-in-human phase I trial in patients with advanced solid tumors

Cancer Res (2020) 80 (16_Supplement): 3014.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal